Log in or Sign up for Free to view tailored content for your specialty!
Diabetes News
Oral roflumilast treatment may induce weight loss in patients with psoriasis
Treating psoriasis with oral roflumilast may induce weight loss, positioning the drug as a potentially attractive alternative for patients with psoriasis, according to a study.
Hybrid closed-loop may be more cost-effective than immune therapies for type 1 diabetes
Hybrid closed-loop insulin delivery systems are more cost-effective for treating type 1 diabetes than immune therapies unless the effects of immune therapies are persistent over a lifetime after one course, according to a speaker.
Log in or Sign up for Free to view tailored content for your specialty!
Efruxifermin with GLP-1RA appears safe, reduces liver fat by 65% in MASH, diabetes
Efruxifermin with a glucagon-like peptide-1 receptor agonist was well-tolerated and reduced hepatic fat fraction and noninvasive markers of fibrosis among patients with metabolic dysfunction-associated steatohepatitis and type 2 diabetes.
Switching to high-deductible health plan increases odds for diabetes-related complications
Adults with diabetes who are forced to switch to a high-deductible health insurance plan have higher risk for diabetes-related complications than those who remain on a regular health plan, according to study data.
Diabetes prevalence higher among people living in historically redlined areas
Neighborhoods that were historically redlined on Home Owners’ Loan Corporation maps in the 1930s are associated with higher diabetes prevalence than non-redlined areas after adjusting for 2010 population figures, according to study data.
Hybrid closed-loop system boosts time in range for pregnant women with type 1 diabetes
Pregnant women with type 1 diabetes achieved a higher time in range and had fewer complications with use of a hybrid closed-loop insulin delivery system compared with continuous glucose monitoring alone, according to a speaker.
Metformin may reduce risk for overall cancer, GI malignancies, meta-analysis shows
The commonly used diabetes drug metformin may reduce risk for cancer, according to study results published in Journal of the National Cancer Institute.
Q&A: People with diabetes can benefit from whole foods, plant-based eating plan
Susan Weiner, MS, RDN, CDCES, FADCES, talks with Lauren Plunkett, RDN, LD, CDCES, about benefits of plant-based nutrition for people with diabetes and strategies for incorporating whole foods and plants into eating plans.
Once-weekly basal insulin noninferior to once-daily insulin for type 1, type 2 diabetes
A once-weekly basal insulin conferred similar changes in HbA1c and time in range as once-daily insulin glargine among adults with type 1 and type 2 diabetes in three phase 2 trials, according to a speaker.
FDA clears automated insulin delivery system for children and adults with type 1 diabetes
The FDA granted 510(k) clearance for an automated insulin delivery system that can measure the volume and flow of insulin within every micro-dose, according to an industry press release.
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read